NT-proBNP serves as a predictor of atrial fibrillation recurrence following cryoballoon, radiofrequency, and pulsed-field ablation.
Absolute Event Rate: 0% vs 0%
The Swiss-AF-PVI registry is registered with ClinicalTrials.gov (NCT03718364).
Bruss et al. (Fri,) reported a other. NT-proBNP serves as a predictor of atrial fibrillation recurrence following cryoballoon, radiofrequency, and pulsed-field ablation.